Pro-Change awarded SBIR contracts totaling $2.7M

PRO-CHANGE BEHAVIOR SYSTEMS recently was awarded three Small Business Innovation Research contracts from the National Institute on Drug Abuse and the National Cancer Institute totaling $2.7 million.
PRO-CHANGE BEHAVIOR SYSTEMS recently was awarded three Small Business Innovation Research contracts from the National Institute on Drug Abuse and the National Cancer Institute totaling $2.7 million.

SOUTH KINGSTOWN – Pro-Change Behavior Systems Inc. recently was awarded three Small Business Innovation Research contracts from the National Institute on Drug Abuse and the National Cancer Institute totaling $2.7 million.
“We are honored that the National Institutes of Health awarded us these special opportunities to develop and test behavior change programs for military personnel and primary care patients,” Janice M. Prochaska, president and CEO of Pro-Change, a research and development company that provides wellness partners with computer and coaching-based programs for changing health-risk behaviors, said in a statement.
Here is information about the three contracts:

  • In Stage-Based Mobile Intervention for Substance Use Disorders in Primary Care, Pro-Change will develop and pilot-test a prototype of a brief mobile-delivered, stage-based, substance-use risk intervention for primary care patients and a clinical dashboard for providers. Tools will be designed to facilitate screening, brief intervention and treatment referral for patients with risky substance use and substance-use disorders.
  • In iWin: Navigating your Path to Well-Being, Pro-Change will evaluate the effectiveness of the individual well-being navigator mobile application in a randomized trial. IWin is a substance-abuse prevention and well-being enhancement program designed specifically for active duty military personnel.
  • In Integrative Platform for Primary Care Delivery of Evidence-Based Cancer Risk Behavior, Pro-Change will test a stage-based, multiple-behavior change intervention in a cluster-randomized trial in community health centers.

The first two projects are federally funded in whole or partially by the National Institute on Drug Abuse, National Institutes of Health and Department of Health and Human Services. The third project is federally funded in whole or partially by the National Cancer Institute, Institutes of Health and Department of Health and Human Services.

No posts to display